Page last updated: 2024-08-22

ozone and sb 656933

ozone has been researched along with sb 656933 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexis, NE; Chen, C; Lazaar, AL; MacDonald, AJ; Sweeney, LE; Tal-Singer, R	1

Trials

1 trial(s) available for ozone and sb 656933

Article	Year
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. British journal of clinical pharmacology, 2011, Volume: 72, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Bronchitis; CD11b Antigen; Chemokine CXCL1; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukocyte Count; Male; Middle Aged; Neutrophil Activation; Neutrophils; Ozone; Peroxidase; Phenylurea Compounds; Receptors, Interleukin-8B; Single-Blind Method; Sputum; Sulfonamides; Young Adult	2011

Article

Year

SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.

British journal of clinical pharmacology, 2011, Volume: 72, Issue:2

Topics: Administration, Oral; Adolescent; Adult; Bronchitis; CD11b Antigen; Chemokine CXCL1; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukocyte Count; Male; Middle Aged; Neutrophil Activation; Neutrophils; Ozone; Peroxidase; Phenylurea Compounds; Receptors, Interleukin-8B; Single-Blind Method; Sputum; Sulfonamides; Young Adult

2011